MedPath

Olanzapine versus sodium valproate for the management of aggression in methadone maintenance treatment

Phase 4
Conditions
Heroin Withdrawal.
Mental and behavioural disorders due to use of opioids
Registration Number
IRCT138801241457N5
Lead Sponsor
Mazandaran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
53
Inclusion Criteria

Inclusion Criteria: Methadone Maintenance Treatment, at least one month negative morphine test, age 18 to 55 years old

Exclusion Criteria

Axis I Diagnosis of mental disorders, Diabetes Mellitus or impaired glucose tolerance test, Hyperlipidemia, Hepatic Diseases, abnormal CBC, Positive pregnancy test for women

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Aggression. Timepoint: weekly for 12 weeks. Method of measurement: Modified Overt Aggression Scale.
Secondary Outcome Measures
NameTimeMethod
Relapse rate, and side effects. Timepoint: randomly, 1 to 8 times per month urine test for relapse rate; and weekly evaluation of side effects. Method of measurement: urine test for relapse evaluation; and physical and mental status examination for side effects.
© Copyright 2025. All Rights Reserved by MedPath